All stocks Β· JENBURPH
JP

Jenburkt Pharmaceuticals Ltd.

JENBURPH BSE Drug Manufacturers - Specialty & Generic Healthcare

Jenburkt Pharmaceuticals Limited manufactures and markets pharmaceutical formulations in India and internationally. The company offers therapeutic solutions, such as analgesic and antipyretics, anthelmintics, anti-arthr…

ISIN INE354A01013
Listed β€”
Quarters tracked 13
Filings 20 docs

About

Jenburkt Pharmaceuticals Limited manufactures and markets pharmaceutical formulations in India and internationally. The company offers therapeutic solutions, such as analgesic and antipyretics, anthelmintics, anti-arthritic, anti-diabetics, anti-infectives, antifungals, antimalarials, antiulcerants and antacids, aphrodisiac, atopic dermatitis, consumer division, cough and cold, muscle relaxants, neuropathic pain, nutraceuticals, and pain management. It offers its products under the Allerzine, CartiSafe Forte, Crisbo, Eberjen, ECOPROT, Frendacid, Fundu, Glajen-E, GLUCOTROL, HYBRITA, Jenflam, La-Viril, LUMA, Lubtriben, Metmin, Nervega-75, Nervijen P, Nervijen, NOCAL, Numox-625, OJEN, ORNEL, Oxicojen, PANTAZOLE, PIRITEXYL, POWERDOL, Powergesic, Rabera, Topcal-M, Trapidol-D, TREGA, TRIBEN, ZENGLOBIN, ZIX, Zix-MR, Zix-PG 200/75, and Zydol Suspension brand names. The company also exports its products. It serves large government, semi-government institutions, missionary hospitals, and public sector enterprises. Jenburkt Pharmaceuticals Limited was incorporated in 1985 and is based in Mumbai, India.

Key Metrics

as of Sep 2026
Market Cap458 Cr
P/E12.80
Div Yield1.99 %
Book Valueβ‚Ή446.00
52w Highβ‚Ή1,321.00
52w Lowβ‚Ή944.00
Face Valueβ‚Ή10.00

Quarterly Results

Rs. Crores Β· hover row for definition
Metric Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023
Sales 35.51 44.63 43.02 45.56 35.53 41.05 36.89 41.22 32.54 38.84 35.66 38.29 29.18
Expenses 29.48 30.38 35.59 32.45 26.58 30.19 28.07 29.79 23.26 28.99 28.47 29.19 22.22
Operating Profit 6.03 14.25 7.43 13.11 8.95 10.86 8.82 11.43 9.28 9.85 7.19 9.10 6.96
OPM % 16.98 31.93 17.27 28.78 25.19 26.46 23.91 27.73 28.52 25.36 20.16 23.77 23.85
Other Income 1.51 0.40 1.82 2.08 2.06 1.88 1.58 1.85 1.41 1.19 1.35 1.10 1.04
Depreciation 0.64 0.81 0.83 0.74 0.72 0.79 0.78 0.64 0.52 0.62 0.63 0.59 0.50
Interest 0.13 0.13 0.12 0.11 0.11 0.11 0.11 0.12 0.11 0.06 0.07 0.07 0.07
Profit before tax 6.77 13.71 8.30 14.34 10.18 11.84 9.51 12.52 10.06 10.36 7.84 9.54 7.43
Tax % 13.00 20.86 28.55 29.08 23.48 27.87 31.65 23.32 26.34 23.94 31.12 23.27 27.73
Net Profit 5.89 10.85 5.93 10.16 7.79 8.54 6.51 9.60 7.42 7.88 5.40 7.32 5.37
EPS in Rs 13.35 24.58 13.44 23.02 17.65 19.35 14.75 21.75 16.81 17.86 12.24 16.59 12.17

Profit & Loss

Annual Β· Rs. Crores
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Sales 169.00152.00142.00137.00124.00109.00119.00123.00115.00103.0094.0085.00
Expenses 125.00111.00109.00106.0097.0089.0099.0098.0091.0084.0077.0070.00
Operating Profit 44.0040.0033.0030.0027.0020.0020.0025.0024.0020.0016.0015.00
OPM % 26.0027.0023.0022.0022.0018.0017.0020.0021.0019.0018.0018.00
Other Income 6.007.005.005.005.004.004.003.003.003.003.002.00
Interest 0.000.000.000.000.000.001.000.000.000.000.000.00
Depreciation 3.003.002.002.002.002.002.001.002.002.002.003.00
Profit before tax 47.0044.0035.0033.0030.0022.0021.0027.0025.0020.0017.0014.00
Tax % 25.0027.0026.0025.0025.0024.0030.0026.0032.0034.0036.0033.00
Net Profit 35.0032.0026.0025.0022.0016.0015.0020.0017.0014.0011.0010.00
EPS in Rs 78.7272.6458.8755.7648.5935.9532.4043.1437.5029.0623.1920.76
Dividend Payout % 26.0025.0026.0026.0025.0028.0025.0024.0024.0028.0031.0030.00

Balance Sheet

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Equity Capital 4.004.004.004.005.005.005.005.005.005.005.005.00
Reserves 193.00167.00141.00118.00113.0094.0075.0073.0057.0050.0036.0029.00
Borrowings 2.004.000.003.007.005.003.007.000.006.005.007.00
Other Liabilities 26.0019.0019.0016.0018.0017.0021.0018.0016.0016.0012.0021.00
Total Liabilities 225.00195.00164.00141.00143.00120.00104.00103.0077.0076.0058.0061.00
Fixed Assets 19.0015.0010.0010.0011.0011.0012.0010.0010.0011.0012.0012.00
CWIP 46.0040.001.001.000.000.000.001.000.000.000.000.00
Investments 27.0021.0017.0011.008.007.004.005.005.002.001.000.00
Other Assets 132.00120.00136.00119.00123.00103.0088.0087.0062.0064.0045.0049.00
Total Assets 225.00195.00164.00141.00143.00120.00104.00103.0077.0076.0058.0061.00

Cash Flows

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Cash from Operating Activity 27.0028.008.0017.009.0019.0015.0013.0016.0010.008.009.00
Cash from Investing Activity -19.00-17.00-1.003.00-1.00-19.00-3.00-11.001.00-10.000.001.00
Cash from Financing Activity -9.00-8.00-7.00-21.00-6.00-1.00-11.00-2.00-18.001.00-5.001.00
Net Cash Flow -2.003.000.00-1.003.000.001.000.00-1.001.002.0011.00
Free Cash Flow 13.008.006.0015.007.0018.0011.0011.0016.0010.005.008.00
CFO/OP % 88.00102.0049.0083.0062.00127.00104.0080.00103.0085.0082.0088.00

Ratios

Annual Β· Days / % β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Debtor Days 53.0050.0050.0045.0045.0047.0055.0068.0040.0032.0023.0032.00
Inventory Days 154.00109.00103.0092.00115.0092.00120.0099.0073.00128.00109.00107.00
Days Payable 91.00100.0075.0067.0083.0056.0058.0066.0044.0072.0044.0054.00
Cash Conversion Cycle 115.0059.0078.0070.0077.0083.00117.00101.0069.0089.0088.0085.00
Working Capital Days 41.0031.0036.0031.0016.0017.0032.0035.0025.0010.006.00-11.00
ROCE % 27.0027.0026.0027.0026.0024.0026.0037.0042.0039.0040.0042.00

Shareholding Pattern

% holding β€” latest first
Holder Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023
Promoters 46.62 46.64 46.65 46.66 46.67 46.68 46.69 46.71 46.71 47.23 47.39 47.42
FIIs 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.38
DIIs 0.12 0.12 0.12 0.12 0.12 0.12 0.12 0.00 0.00 0.00 0.00 0.00
Public 53.27 53.24 53.24 53.22 53.21 53.20 53.20 53.28 53.29 52.78 52.63 51.21
No. of Shareholders 7,103 6,999 7,163 6,855 6,712 6,987 6,901 6,628 6,419 6,316 6,021 5,872

Corporate Actions

23 records
ActionEx DateRecord DateRatioAmount (β‚Ή)Notes
Dividend 11 Jul 2025 11 Jul 2025 β€” 18.00
Dividend 23 Jul 2024 β€” β€” 15.30
Dividend 19 Jul 2023 β€” β€” 14.40
Dividend 21 Jul 2022 β€” β€” 12.00
Dividend 30 Aug 2021 β€” β€” 10.20
Dividend 18 Mar 2020 19 Mar 2020 β€” 8.10
Dividend 22 Jul 2019 β€” β€” 10.20
Dividend 23 Jul 2018 β€” β€” 6.00
Dividend 27 Mar 2018 28 Mar 2018 β€” 3.00
Other 09 Nov 2017 10 Nov 2017 β€” β€” Buy Back of Shares
Dividend 21 Jul 2017 β€” β€” 8.10
Dividend 19 Jul 2016 β€” β€” 0.90
Dividend 17 Mar 2016 18 Mar 2016 β€” 6.30
Dividend 31 Aug 2015 β€” β€” 6.30
Dividend 03 Sep 2014 β€” β€” 5.10
Dividend 18 Sep 2013 β€” β€” 4.20
Dividend 23 Jul 2012 β€” β€” 3.50
Dividend 21 Jul 2011 β€” β€” 3.50
Dividend 21 Jul 2010 β€” β€” 3.00
Dividend 23 Jul 2009 β€” β€” 1.80
Dividend 23 Jul 2008 β€” β€” 1.25
Dividend 18 Jul 2007 β€” β€” 1.25
Other 04 Jan 2001 19 Jan 2001 β€” β€” Voluntary Delisting of Shares

Announcements

5 filings